share_log

红日药业(300026.SZ):酮咯酸氨丁三醇注射液目前在CDE审评中

Hongri Pharmaceutical (300026.SZ): Ketorolac tromethanol injection is currently under CDE review

Gelonghui Finance ·  Mar 29 04:16

Gelonghui, March 29丨An investor asked Hongri Pharmaceutical (300026.SZ) on the investor interactive platform, “The consistency evaluation of your company's ketorolac tromethotriol injection completed various technical reviews at the end of August 2023. Why hasn't it been approved until now?” The company replied that ketorolac and tromethotriol injections are currently under CDE review.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment